MIR3192

Across TCGA pan-cancer cohorts, MIR3192 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MIR3192 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher MIR3192 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3192 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCS show a favorable association.

KICH, MESO, and LIHC are the cancer types where MIR3192 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	II,III,IV	0.413	0.916	<.001	54	view →
MESO	OS	Tertile	All	0.174	0.577	.006	36	view →
LIHC	OS	Tertile	II,III,IV	0.485	0.744	.002	35	view →
BRCA	OS	Tertile	II,III,IV	0.552	0.670	<.001	33	view →
UCEC	DFS	Tertile	All	0.521	0.664	.009	24	view →
LUAD	OS	Quartile	III,IV	0.782	0.555	.017	20	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
UCS	DFS	Tertile	IV	0.981	0.510	.020	18	view →
COAD	OS	Median	All	0.480	0.642	.007	11	view →
READ	DFS	Tertile	III,IV	0.557	0.820	.006	11	view →
UVM	DFS	Tertile	III,IV	0.344	0.629	.039	10	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MIR3192–KICH (DFS)

Open the KICH breakdown →